This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Wednesday, April 13, 2016
Does sustained virologic response represent a cure for hepatitis C virus infection?
Expert: SVR does not equate to a cure in HCV
Healio
See more from Highlights from International Liver Congress
BARCELONA — In this video perspective from the International Liver Congress 2016, Ronald Koretz, MD, Emeritus professor of medicine at University of California Los Angeles School of Medicine, discusses results of a systematic review that asks: Does sustained virologic response represent a cure for hepatitis C virus infection?
Continue reading....
No comments:
Post a Comment